| | |
| Clinical data | |
|---|---|
| Other names | 3,4-Ethylenedioxyamphetamine; EDA; EDA-6; α-Methyl-1,4-benzodioxan-6-ethylamine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C11H15NO2 |
| Molar mass | 193.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3,4-Ethylenedioxyamphetamine (EDA), also known as EDA-6, is a drug of the phenethylamine, amphetamine, and EDxx families related to 3,4-methylenedioxyamphetamine (MDA). [1] It is closely related to analogues including 3,4-ethylenedioxymethamphetamine (EDMA), 3,4-ethylidenedioxyamphetamine (EIDA), and 3,4-isopropylidenedioxyamphetamine (IDA). [1] [2] EDMA, the N-methylated analogue of EDA, is known to be a serotonin–norepinephrine–dopamine releasing agent (SNDRA). [3] According to Alexander Shulgin however, the drug only produced limited psychoactive effects in humans at doses in the range of 150 to 250 mg. [4] [1]
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| Stimulants |
|
|---|---|
| Depressants |
|
| Hallucinogens |
|
| Entactogens |
|
| Psychiatric drugs |
|
| Others |
|
| | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |